Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07792681 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults

Name: Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults — clinical trial record (NCT07792681)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 2/3

SponsorBrise Pharmaceuticals Co., Ltd.

Started2026-09-15

View on ClinicalTrials.gov ↗

The purpose of this study is to compare the efficacy and safety of BR005-036C versus placebo in subjects with Acute Migraines

Trial Details

NCT Number	NCT07792681
Lead Sponsor	Brise Pharmaceuticals Co., Ltd.
Conditions	Migraine, With or Without Aura
Enrollment	2,079 participants
Start Date	2026-09-15
Primary Completion	2028-06-30 (estimated)
Study Completion	2028-07-31 (estimated)
Updated on ClinicalTrials.gov	2026-08-28